Irreversible renal failure in a patient with chronic lymphocytic leukemia treated with fludarabine
Gespeichert in:
| Veröffentlicht in: | Annals of hematology 1999-02, Vol.78 (2), p.109-110 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 110 |
|---|---|
| container_issue | 2 |
| container_start_page | 109 |
| container_title | Annals of hematology |
| container_volume | 78 |
| creator | Timuragaoglu, A Karadogan, I Undar, L |
| description | |
| doi_str_mv | 10.1007/s002770050485 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1015370978</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2667876491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c286t-de89b99f66fce17d7f5959a1562aa27abab6bff660716a587e4eebf5ed9ef4443</originalsourceid><addsrcrecordid>eNpVkE1LxDAQhoMo7rp69CoBz9VJmzTNURa_YMGLnkvSTtis_TJJlf33dukedC4zMM-8MA8h1wzuGIC8DwCplAACeCFOyJLxLE1AFPyULEFlKhFTLchFCDsAlhY8PSeL6bJQkLElMa_e4zf64EyD1GOnG2q1a0aP1HVU00FHh12kPy5uabX1fecq2uzbYdtX-3iYcfzE1mkaPeqI9UzaZqy118Z1eEnOrG4CXh37inw8Pb6vX5LN2_Pr-mGTVGmRx6TGQhmlbJ7bCpmspRVKKM1EnmqdSm20yY2d1iBZrkUhkSMaK7BWaDnn2YrczrmD779GDLHc9aOfHgolAyYyCUoWE5XMVOX7EDzacvCu1X4_QeXBaPnP6MTfHFNH02L9h54VZr98IXKK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1015370978</pqid></control><display><type>article</type><title>Irreversible renal failure in a patient with chronic lymphocytic leukemia treated with fludarabine</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Timuragaoglu, A ; Karadogan, I ; Undar, L</creator><creatorcontrib>Timuragaoglu, A ; Karadogan, I ; Undar, L</creatorcontrib><identifier>ISSN: 0939-5555</identifier><identifier>EISSN: 1432-0584</identifier><identifier>DOI: 10.1007/s002770050485</identifier><identifier>PMID: 10089031</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Acute Kidney Injury - etiology ; Antimetabolites, Antineoplastic - adverse effects ; Antimetabolites, Antineoplastic - therapeutic use ; Autoantibodies - immunology ; Erythrocytes - immunology ; Fatal Outcome ; Glomerulonephritis - etiology ; Humans ; Immune Complex Diseases - etiology ; Kidney Failure, Chronic - etiology ; Kidney Failure, Chronic - therapy ; Leukemia, Lymphocytic, Chronic, B-Cell - complications ; Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy ; Male ; Middle Aged ; Renal Dialysis ; Salvage Therapy ; Vidarabine - adverse effects ; Vidarabine - analogs & derivatives ; Vidarabine - therapeutic use</subject><ispartof>Annals of hematology, 1999-02, Vol.78 (2), p.109-110</ispartof><rights>Springer-Verlag Berlin Heidelberg 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c286t-de89b99f66fce17d7f5959a1562aa27abab6bff660716a587e4eebf5ed9ef4443</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10089031$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Timuragaoglu, A</creatorcontrib><creatorcontrib>Karadogan, I</creatorcontrib><creatorcontrib>Undar, L</creatorcontrib><title>Irreversible renal failure in a patient with chronic lymphocytic leukemia treated with fludarabine</title><title>Annals of hematology</title><addtitle>Ann Hematol</addtitle><subject>Acute Kidney Injury - etiology</subject><subject>Antimetabolites, Antineoplastic - adverse effects</subject><subject>Antimetabolites, Antineoplastic - therapeutic use</subject><subject>Autoantibodies - immunology</subject><subject>Erythrocytes - immunology</subject><subject>Fatal Outcome</subject><subject>Glomerulonephritis - etiology</subject><subject>Humans</subject><subject>Immune Complex Diseases - etiology</subject><subject>Kidney Failure, Chronic - etiology</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - complications</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Renal Dialysis</subject><subject>Salvage Therapy</subject><subject>Vidarabine - adverse effects</subject><subject>Vidarabine - analogs & derivatives</subject><subject>Vidarabine - therapeutic use</subject><issn>0939-5555</issn><issn>1432-0584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpVkE1LxDAQhoMo7rp69CoBz9VJmzTNURa_YMGLnkvSTtis_TJJlf33dukedC4zMM-8MA8h1wzuGIC8DwCplAACeCFOyJLxLE1AFPyULEFlKhFTLchFCDsAlhY8PSeL6bJQkLElMa_e4zf64EyD1GOnG2q1a0aP1HVU00FHh12kPy5uabX1fecq2uzbYdtX-3iYcfzE1mkaPeqI9UzaZqy118Z1eEnOrG4CXh37inw8Pb6vX5LN2_Pr-mGTVGmRx6TGQhmlbJ7bCpmspRVKKM1EnmqdSm20yY2d1iBZrkUhkSMaK7BWaDnn2YrczrmD779GDLHc9aOfHgolAyYyCUoWE5XMVOX7EDzacvCu1X4_QeXBaPnP6MTfHFNH02L9h54VZr98IXKK</recordid><startdate>19990201</startdate><enddate>19990201</enddate><creator>Timuragaoglu, A</creator><creator>Karadogan, I</creator><creator>Undar, L</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>19990201</creationdate><title>Irreversible renal failure in a patient with chronic lymphocytic leukemia treated with fludarabine</title><author>Timuragaoglu, A ; Karadogan, I ; Undar, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c286t-de89b99f66fce17d7f5959a1562aa27abab6bff660716a587e4eebf5ed9ef4443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Acute Kidney Injury - etiology</topic><topic>Antimetabolites, Antineoplastic - adverse effects</topic><topic>Antimetabolites, Antineoplastic - therapeutic use</topic><topic>Autoantibodies - immunology</topic><topic>Erythrocytes - immunology</topic><topic>Fatal Outcome</topic><topic>Glomerulonephritis - etiology</topic><topic>Humans</topic><topic>Immune Complex Diseases - etiology</topic><topic>Kidney Failure, Chronic - etiology</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - complications</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Renal Dialysis</topic><topic>Salvage Therapy</topic><topic>Vidarabine - adverse effects</topic><topic>Vidarabine - analogs & derivatives</topic><topic>Vidarabine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Timuragaoglu, A</creatorcontrib><creatorcontrib>Karadogan, I</creatorcontrib><creatorcontrib>Undar, L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Annals of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Timuragaoglu, A</au><au>Karadogan, I</au><au>Undar, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Irreversible renal failure in a patient with chronic lymphocytic leukemia treated with fludarabine</atitle><jtitle>Annals of hematology</jtitle><addtitle>Ann Hematol</addtitle><date>1999-02-01</date><risdate>1999</risdate><volume>78</volume><issue>2</issue><spage>109</spage><epage>110</epage><pages>109-110</pages><issn>0939-5555</issn><eissn>1432-0584</eissn><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>10089031</pmid><doi>10.1007/s002770050485</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0939-5555 |
| ispartof | Annals of hematology, 1999-02, Vol.78 (2), p.109-110 |
| issn | 0939-5555 1432-0584 |
| language | eng |
| recordid | cdi_proquest_journals_1015370978 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Acute Kidney Injury - etiology Antimetabolites, Antineoplastic - adverse effects Antimetabolites, Antineoplastic - therapeutic use Autoantibodies - immunology Erythrocytes - immunology Fatal Outcome Glomerulonephritis - etiology Humans Immune Complex Diseases - etiology Kidney Failure, Chronic - etiology Kidney Failure, Chronic - therapy Leukemia, Lymphocytic, Chronic, B-Cell - complications Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Male Middle Aged Renal Dialysis Salvage Therapy Vidarabine - adverse effects Vidarabine - analogs & derivatives Vidarabine - therapeutic use |
| title | Irreversible renal failure in a patient with chronic lymphocytic leukemia treated with fludarabine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T21%3A07%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Irreversible%20renal%20failure%20in%20a%20patient%20with%20chronic%20lymphocytic%20leukemia%20treated%20with%20fludarabine&rft.jtitle=Annals%20of%20hematology&rft.au=Timuragaoglu,%20A&rft.date=1999-02-01&rft.volume=78&rft.issue=2&rft.spage=109&rft.epage=110&rft.pages=109-110&rft.issn=0939-5555&rft.eissn=1432-0584&rft_id=info:doi/10.1007/s002770050485&rft_dat=%3Cproquest_cross%3E2667876491%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1015370978&rft_id=info:pmid/10089031&rfr_iscdi=true |